查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1474934

IV 敷料市場規模、佔有率和趨勢分析報告：按類型、最終用途、地區、細分市場預測，2024-2030 年

IV Dressing Market Size, Share & Trends Analysis Report By Type (Transparent, Translucent), By End-use (Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

靜脈注射敷料市場成長與趨勢：

Grand View Research 的最新報告顯示，到 2030 年，全球靜脈輸液敷料市場規模預計將達到 12.1 億美元。

預計 2024 年至 2030 年複合年成長率為 5.50%。 CLABSI 和 CRBSI 等血源性感染的增加以及住院患者人數的增加預計將提振市場需求。此外，老年人口的增加和慢性病盛行率的增加也是推動市場成長的因素。例如，根據世界衛生組織稱，2015年至2050年間，老年人口比例預計將加倍，從12%增至22%，使老年成為慢性病的重要危險因子。提高靜脈療法在治療包括癌症在內的各種慢性疾病方面的認知和採用，預計將推動市場成長。多家公司正在推出新的靜脈注射療法。

例如，2023 年 1 月，Glenmark Pharmaceuticals Ltd. 在印度推出了 AKYNZEO IV，一種靜脈感染劑，用於預防化療引起的嘔吐和噁心。主要企業的策略性舉措（例如收購）預計將有助於市場成長。例如，2022年9月，B. Braun Medical Inc.從Starboard Medical收購了導管固定產品。這項措施預計將改善患者照護並擴大公司的靜脈注射治療產品，包括靜脈注射敷料。此外，主要企業的地理擴張活動預計將促進市場成長。例如，2022 年 1 月，Smith + Nephew 開設了一個新的商業地點，以擴大其在北歐地區的產品供應。

靜脈注射敷料市場報告亮點

  • 透明產品細分市場在2023年佔據最大市場佔有率，預計2024年至2030年將以5.71%的最快複合年成長率成長。
  • 這是由於引入了一種新型透明膜敷料，其凝膠貼片浸有洛赫西定酸氯己定，可在導管使用期間對部位進行持續消毒。
  • 由於醫療保健投資高、住院人數不斷增加以及感染疾病和慢性病的發病率，醫院最終用途細分市場在 2023 年佔據最大收入佔有率，為 45.39%。
  • 2023年，北美地區的銷售佔有率最大，為45.46%。這是由於發達的醫療基礎設施、大量的老年人口以及對靜脈治療的認知和採用不斷提高。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章第4章敷料市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • IV 敷料市場分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章 IV 服裝：類型估計/趨勢分析

  • 靜脈輸液敷料市場：類型變化分析
    • 透明的
    • 半透明

第5章 IV 選礦：最終用途估算與趨勢分析

  • 靜脈注射敷料市場：最終用途變化分析

第6章第4章 敷料市場：區域估算與趨勢分析

  • 全球區域市場概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商情況
    • 3M
    • RICHARDSON HEALTHCARE, INC.
    • MEDLINE INDUSTRIES
    • SMITH &NEPHEW
    • CARDINAL HEALTH
    • CONVATEC GROUP PLC
    • PAUL HARTMANN AG
    • LOHMANN &RAUSCHER（L&R）
    • MCKESSON CORPORATION
    • MOLNLYCKE HEALTH CARE AB
    • DERMARITE INDUSTRIES, LLC
    • DEROYAL INDUSTRIES, INC.
    • BSN MEDICAL
    • DYNAREX CORPORATION.
    • KOMAL HEALTH CARE PVT. LTD.
    • SENTRY MEDICAL
    • SHANDONG DERMCOSY MEDICAL CO.,LTD.
Product Code: GVR-4-68040-247-2

IV Dressing Market Growth & Trends:

The global IV dressing market size is anticipated to reach USD 1.21 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 5.50% from 2024 to 2030. Increasing cases of blood infections, such as CLABSI and CRBSI, and a rising number of hospital admissions are likely to boost market demand. Also, the rising geriatric population and increasing prevalence of chronic disorders are factors contributing to market growth. For instance, according to the WHO, between 2015 and 2050, the proportion of geriatric population is expected to double from 12% to 22%, making old age a significant risk factor for developing chronic disorders. A rise in awareness and adoption of IV therapy for treating various chronic diseases including cancer is anticipated to drive market growth. Various players are launching novel IV therapies.

For instance, in January 2023, Glenmark Pharmaceuticals Ltd. launched the IV infection formulation AKYNZEO IV in India to prevent chemotherapy-induced vomiting and nausea. Strategic initiatives undertaken by top players, such as acquisitions, are expected to contribute to market growth. For instance, in September 2022, B. Braun Medical Inc. acquired catheter securement products from Starboard Medical. This initiative was anticipated to improve patient care and extend the company's IV therapy offering including IV dressing. Furthermore, geographical expansion activities by key players are projected to boost market growth. For instance, in January 2022, Smith+Nephew inaugurated a new commercial hub to increase the company's product offerings in the Nordic region.

IV Dressing Market Report Highlights:

  • The transparent product segment accounted for the largest market share in 2023 and is expected to grow at the fastest CAGR of 5.71% from 2024 to 2030
  • This is owing to the introduction of a novel transparent film dressing with a chlorhexidine gluconate-impregnated gelpatch to offer ongoing disinfection of the site throughout the duration of the catheter
  • The hospitals end-use segment held the largest revenue share of 45.39% in 2023 owing to the high healthcare investments, a rise in the number of hospitalizations, and incidences of infectious & chronic diseases
  • North America captured the largest revenue share of 45.46% in 2023. This is owing to the well-developed healthcare infrastructure, high geriatric population, and rise in the awareness & adoption of IV therapies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End Use
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
      • 1.6.1.1. Commodity flow analysis (Model 1)
      • 1.6.1.2. Approach 1: Commodity flow approach
      • 1.6.1.3. Volume price analysis (Model 2)
      • 1.6.1.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. I.V. Dressing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing cases of blood infections such as CLABSI and CRBSI
      • 3.2.1.2. Increasing hospital admission
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Complications associated with I.V. dressing
  • 3.3. I.V. Dressing Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. I.V. Dressing: Type Estimates & Trend Analysis

  • 4.1. I.V. Dressing Market: Type Movement Analysis
    • 4.1.1. Transparent
      • 4.1.1.1. Transparent market estimates and forecast, 2018 - 2030
    • 4.1.2. Translucent
      • 4.1.2.1. Translucent market estimates and forecast, 2018 - 2030

Chapter 5. I.V. Dressing: End-use Estimates & Trend Analysis

  • 5.1. I.V. Dressing Market: End-use Movement Analysis
    • 5.1.1. Hospitals
      • 5.1.1.1. Hospitals market estimates and forecast 2018 to 2030, (USD million)
    • 5.1.2. Clinics
      • 5.1.2.1. Clinics Institutes market estimates and forecast 2018 to 2030, (USD Million)
    • 5.1.3. Others
      • 5.1.3.1. Others market estimates and forecast 2018 to 2030, (USD million)

Chapter 6. I.V. Dressing Market: Regional Estimates & Trend Analysis

  • 6.1. Global Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Target Disease Prevalence
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Target Disease Prevalence
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Target Disease Prevalence
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Target Disease Prevalence
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Target Disease Prevalence
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Target Disease Prevalence
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Target Disease Prevalence
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Target Disease Prevalence
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Target Disease Prevalence
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Target Disease Prevalence
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.2. China
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.3. Japan
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Target Disease Prevalence
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Target Disease Prevalence
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Target Disease Prevalence
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.6. MEA
    • 6.6.1. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.3. South Africa
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2022
    • 7.3.4. 3M
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. RICHARDSON HEALTHCARE, INC.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. MEDLINE INDUSTRIES
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. SMITH & NEPHEW
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. CARDINAL HEALTH
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. CONVATEC GROUP PLC
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. PAUL HARTMANN AG
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. LOHMANN & RAUSCHER (L&R)
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. MCKESSON CORPORATION
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. MOLNLYCKE HEALTH CARE AB
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. DERMARITE INDUSTRIES, LLC
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. DEROYAL INDUSTRIES, INC.
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. BSN MEDICAL
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives
    • 7.3.17. DYNAREX CORPORATION.
      • 7.3.17.1. Company overview
      • 7.3.17.2. Financial performance
      • 7.3.17.3. Product benchmarking
      • 7.3.17.4. Strategic initiatives
    • 7.3.18. KOMAL HEALTH CARE PVT. LTD.
      • 7.3.18.1. Company overview
      • 7.3.18.2. Financial performance
      • 7.3.18.3. Product benchmarking
      • 7.3.18.4. Strategic initiatives
    • 7.3.19. SENTRY MEDICAL
      • 7.3.19.1. Company overview
      • 7.3.19.2. Financial performance
      • 7.3.19.3. Product benchmarking
      • 7.3.19.4. Strategic initiatives
    • 7.3.20. SHANDONG DERMCOSY MEDICAL CO.,LTD.
      • 7.3.20.1. Company overview
      • 7.3.20.2. Financial performance
      • 7.3.20.3. Product benchmarking
      • 7.3.20.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global I.V. Dressing Market, By Region 2018 - 2030 (USD Million)
  • Table 4. Global I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 5. Global I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 6. North America I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 8. North America I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 9. U.S. I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 10. U.S. I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11. Canada I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 12. Canada I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13. Europe I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 14. Europe I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 15. Europe I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16. UK I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 17. UK I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18. Germany I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 19. Germany I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20. France I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 21. France I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22. Italy I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 23. Italy I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24. Spain I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 25. Spain I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26. Denmark I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 27. Denmark I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28. Sweden I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 29. Sweden I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30. Norway I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 31. Norway I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32. Asia Pacific I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35. Japan I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 36. Japan I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37. China I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 38. China I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 39. India I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 40. India I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41. Australia I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 42. Australia I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43. Thailand I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 44. Thailand I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 45. South Korea I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 46. South Korea I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47. Latin America I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 48. Latin America I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 49. Latin America I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 50. Brazil I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 51. Brazil I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52. Mexico I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 53. Mexico I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54. Argentina I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 55. Argentina I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56. MEA I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 57. MEA I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 58. MEA I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59. South Africa I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 60. South Africa I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63. UAE I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 64. UAE I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 66. Kuwait Arabia I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 I.V. Dressing market: Market snapshot
  • Fig. 9 I.V. Dressing market: Market segmentation
  • Fig. 10 I.V. Dressing market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 I.V. Dressing market driver impact
  • Fig. 16 I.V. Dressing market restraint impact
  • Fig. 17 I.V. Dressing market porter's five forces analysis
  • Fig. 18 I.V. Dressing market PESTEL analysis
  • Fig. 19 I.V. Dressing market: Type movement Analysis
  • Fig. 20 I.V dressing market: type outlook and key takeaways
  • Fig. 21 Transparent market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Translucent market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 I.V. dressing market: End use movement Analysis
  • Fig. 24 I.V. dressing market: End use outlook and key takeaways
  • Fig. 25 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global I.V. Dressing market: Regional movement analysis
  • Fig. 29 Global I.V. Dressing market: Regional outlook and key takeaways
  • Fig. 30 Global market share, by region
  • Fig. 31 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)